These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9283714)

  • 1. Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat.
    Jackson HC; Needham AM; Hutchins LJ; Mazurkiewicz SE; Heal DJ
    Br J Pharmacol; 1997 Aug; 121(8):1758-62. PubMed ID: 9283714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats.
    Thomas GH; Babbs AJ; Chatfield RE; Krülle TM; Widdowson PS; Provost D; McCormack JG
    Obesity (Silver Spring); 2009 Mar; 17(3):467-73. PubMed ID: 19219064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine.
    Heal DJ; Aspley S; Prow MR; Jackson HC; Martin KF; Cheetham SC
    Int J Obes Relat Metab Disord; 1998 Aug; 22 Suppl 1():S18-28; discussion S29. PubMed ID: 9758240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat.
    Jackson HC; Bearham MC; Hutchins LJ; Mazurkiewicz SE; Needham AM; Heal DJ
    Br J Pharmacol; 1997 Aug; 121(8):1613-8. PubMed ID: 9283694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine uptake inhibitor-induced rotation in 6-hydroxydopamine-lesioned rats involves both D1 and D2 receptors but is modulated through 5-hydroxytryptamine and noradrenaline receptors.
    Lane EL; Cheetham S; Jenner P
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1124-31. PubMed ID: 15542624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents.
    Heal DJ; Cheetham SC; Prow MR; Martin KF; Buckett WR
    Br J Pharmacol; 1998 Sep; 125(2):301-8. PubMed ID: 9786502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular electrophysiological effects of chronic fluoxetine and duloxetine administration on serotonergic responses in the aging hippocampus.
    Smith JE; Lakoski JM
    Synapse; 1998 Nov; 30(3):318-28. PubMed ID: 9776135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sibutramine-induced anorexia: potent, dose-dependent and behaviourally-selective profile in male rats.
    Tallett AJ; Blundell JE; Rodgers RJ
    Behav Brain Res; 2009 Mar; 198(2):359-65. PubMed ID: 19061919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of preexposure to dexfenfluramine, phentermine, dexfenfluramine-phentermine, or fluoxetine on sibutramine-induced hypophagia in the adult rat.
    Wellman PJ; Jones SL; Miller DK
    Pharmacol Biochem Behav; 2003 Apr; 75(1):103-14. PubMed ID: 12759118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor.
    Gundlah C; Martin KF; Heal DJ; Auerbach SB
    J Pharmacol Exp Ther; 1997 Nov; 283(2):581-91. PubMed ID: 9353373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia.
    Raiteri M; Bonanno G; Vallebuona F
    J Pharmacol Exp Ther; 1995 May; 273(2):643-9. PubMed ID: 7752066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locomotion is the major determinant of sibutramine-induced increase in energy expenditure.
    Golozoubova V; Strauss F; Malmlöf K
    Pharmacol Biochem Behav; 2006 Apr; 83(4):517-27. PubMed ID: 16647108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
    Roth JD; Trevaskis JL; Wilson J; Lei C; Athanacio J; Mack C; Kesty NC; Coffey T; Weyer C; Parkes DG
    Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus properties of cocaine: enhancement by monoamine reuptake blockers.
    Kleven MS; Koek W
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1015-25. PubMed ID: 9495862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine.
    Cheetham SC; Viggers JA; Slater NA; Heal DJ
    Neuropharmacology; 2000 Aug; 39(11):2028-35. PubMed ID: 10963746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats.
    Rowley HL; Butler SA; Prow MR; Dykes SG; Aspley S; Kilpatrick IC; Heal DJ
    Synapse; 2000 Nov; 38(2):167-76. PubMed ID: 11018791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal protein restriction reduces the inhibitory action of serotonin on food intake.
    Lopes de Souza S; Orozco-Solis R; Grit I; Manhães de Castro R; Bolaños-Jiménez F
    Eur J Neurosci; 2008 Mar; 27(6):1400-8. PubMed ID: 18331342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of the thermogenic effect of Metabolite 2 (BTS 54 505), a major pharmacologically active metabolite of the novel anti-obesity drug, sibutramine.
    Liu YL; Heal DJ; Stock MJ
    Int J Obes Relat Metab Disord; 2002 Sep; 26(9):1245-53. PubMed ID: 12187403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants.
    Larsen MH; Hay-Schmidt A; Rønn LC; Mikkelsen JD
    Eur J Pharmacol; 2008 Jan; 578(2-3):114-22. PubMed ID: 17950272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of dopamine and norepinephrine reuptake produces additive effects on energy balance in lean and obese mice.
    Billes SK; Cowley MA
    Neuropsychopharmacology; 2007 Apr; 32(4):822-34. PubMed ID: 16841072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.